Navigation Links
Video: Allen Institute for Brain Science Unveils World's First Genome-Wide Spinal Cord Atlas
Date:7/17/2008

es a unique opportunity for donors to support specific projects advancing scientific knowledge in target areas.

The Institute's unique funding model, designed to transform public, private and foundation funds into breakthrough scientific discoveries, supported the Allen Spinal Cord Atlas' dedicated consortium of public and private entities -- including The ALS Association, PVA Research Foundation, Wyeth Research, PEMCO Insurance, National Multiple Sclerosis Society, International Spinal Research Trust and philanthropist and Institute founder Paul G. Allen, as well as numerous anonymous donors.

Initial Allen Spinal Cord Atlas Gene Information Released on Internet

Since mice and humans share 90 percent of genes, and the mouse is a well-established model for the study of human diseases, the Allen Spinal Cord Atlas will provide scientists and physicians with an expanded foundation of knowledge to discover new treatments for numerous diseases and disorders. The Allen Spinal Cord Atlas will utilize the same concept and technology as the Institute's inaugural Allen Brain Atlas.

From start to finish, the Allen Spinal Cord Atlas will be completed within a swift, twelve-month timeframe. While inaugural data -- approximately 2,000 genes -- from the Allen Spinal Cord Atlas is now available, the Institute will continue to follow its founding mission and upload additional information until the projected completion in early 2009. It is estimated that hundreds of users from universities, research institutes, pharmaceutical companies and government organizations will use the atlas.

When completed, the Allen Spinal Cord Atlas will detail approximately 20,000 genes including data from youth and adult developmental stages. It will also feature data across the full length of the spinal cord as well as anatomical reference sections.

Contact:

Aaron Blank,

for the Allen Institute for Brain Science

(206) 343-1543

'/>"/>

SOURCE Allen Institute for Brain Science
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Video: Chatto Skincare Unprecedented Breakthrough
2. Video: Worlds Heaviest Man Celebrates Birthday and Weight Loss Milestone
3. Video: The Nevada Division of Insurance Launches 2008 Health Sham Insurance Campaign
4. Video: Zix Corporation Issues Statement Supporting Bipartisan Push for Medicare e-Prescribing Requirement
5. Video: GlaxoSmithKline Consumer Healthcare Offers Free Nicotine Lozenges for All Certified Pilots and Air Traffic Controllers to Help Them Safely Quit Smoking
6. Video: ADA 22nd New Dentist Conference: Jazzed in New Orleans
7. Video: Most Americans Dont Know Better Fats Benefit Heart Health
8. Video: The Ad Council Partners With UNICEF to Promote and Distribute Myanmar Cyclone PSAs Filmed by A-List Celebrities
9. Video: Ocean Spray Revitalizes Americans Naturally With Free Fuel for Their Bodies
10. Video: Pediatric Brain Tumor Foundation Gives $6 Million Grant to Duke
11. Video: 18th Annual Retirement Confidence Survey(R): Health Care, Economy Major Concerns in Workers Record Drop in Retirement Confidence

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...Animal studies suggest that adding flaxseed oil to... post-menopausal women and women with diabetes, ac...ational Journal of Food Safety, Nutrition and Publ...tional Research Center, in Cairo, Egypt, have stud...uated how flaxseed oil in the diet might delay the...
(Date:11/23/2009)...Since 1996, crop plants genetically modified to pr... insects, yet safe for people, have been planted o...pularity of these Bt crops, named after the bacter...lity to kill some major pests, allowing farmers to...ducing insecticide sprays. , However, since inse...
(Date:11/23/2009)...ding drug to chemo regimen may improve patient out.... 23 (HealthDay News) -- A new combination drug th...nced biliary-tract cancers, researchers say. , ...Cancer Center in Boston found that survival and tu...(Avastin), an angiogenesis inhibitor that has help...
(Date:11/23/2009)...V patients who have it take longer to get sick, st... News) -- Scientists report that a genetic variati... progression in HIV-infected patients. , In f... longer to develop AIDS and die of complications o...that vary across individuals that make a person mo...
(Date:11/23/2009)...,, ,, NASHVILLE,Tenn.,Nov.23/PRNewswire...gedcaremarketintelligence,reportsthatself-insuredm...thCareGrouphaveexperiencedanaggregatehealthcare-co...tthreeyearsofparticipationinahigh-performanceprovi... thecoalitionfoundtheseself-insuredmembercompanies...
Breaking Medicine News(10 mins):Health News:Flaxseed oil and osteoporosis 2Health News:Insect resistance to Bt crops can be predicted, monitored and managed 2Health News:Combo Treatment Beneficial in Biliary-Tract Cancer Study 2Health News:Genetic Variant Slows AIDS Progression 2Health News:Milwaukee Employers See Cost Savings with High-Performance Provider Network 2
...is about the same as using drugs for treatment, st...y News) -- Giving blood transfusions to treat anem...ially lethal blood clots, say University of Roches...lyzed data on more than 70,500 cancer patients who...
...28 HMS Holdings Corp.,(Nasdaq: HMSY ) today ann...er,Jaffray Healthcare Conference, which will be he.... , Walter Hosp, CFO, will present on Tuesday, D...rity services for government healthcare programs.,...
...ght boost understanding of the disease generally, ...hDay News) -- The adult children of people with th... being sought for a new study to better understand...nset form of Alzheimer,s are needed for the six-ye...
...cals make some playthings unfit for kids, report c... -- Plastic fish squirt guns and plastic ponies co...ates. , Toy cars and toy earrings laced with lead....day season, but that they shouldn,t find their way...
..., Nov. 28 VIDA Diagnostics Inc. announced,today t... (PW2) has obtained,FDA 510(k) clearance for sale....ng image analysis software from,VIDA and comprises...ystem measurement functions. , "We are privi...
... Serving as a model for public health a...organization has launched the D*action Community P...nd individuals committed to solving the worldwide ... p.m. , San Diego, CA (PR...
Other Medicine News:Health News:Transfusing Anemic Cancer Patients Boosts Clot Risk 2Health News:Study Recruiting From Alzheimer's-Prone Families 2Health News:Beware of Toxic Toys This Holiday Season 2Health News:Beware of Toxic Toys This Holiday Season 3Health News:VIDA Diagnostics Gains FDA Approval for Comprehensive Lung Analysis Software 2Health News:Grassrootshealth Launches D*action Community Project to Solve Vitamin D Deficiency Crisis 2Health News:Grassrootshealth Launches D*action Community Project to Solve Vitamin D Deficiency Crisis 3
(Date:11/23/2009)...BridgePointMedicalannouncedtodaythatitreceivedEuro...ripheralChronicTotalOcclusion(CTO)CrossingSystemco...Stingray®CTORe-EntrySystem.TheBridgePointSyst...dtonavigatehighlydiseasedarteriesinpreparationforb..., TheNationalHeart,LungandBloodInstitute(NHLBI)est...
(Date:11/23/2009)...wire-FirstCall/-- LexiconPharmaceuticals,Inc. (Nas...hase2clinicalstudywith LX1031 inpatientswithnon-co...edatGASTRO2009inLondonthisweek.Resultsfromthestudy...illbepresentedbyDr. PhilipM.Brown ,Lexicon,ssenior...09at2:30pmlocaltimeatthesessionentitled,"Therapeut...
(Date:11/23/2009)...e-FirstCall/--WoundManagementTechnologies,Inc.,(OT...altymedicalproducts,announcedthatithasfileditQ3200...ementbusinessupdatetoillustratethedevelopmentsduri...33.5%to$102,926vs.Q32008salesof$77,084. , Sha....Q32008shareholderequityof$(321,257) , Totala...
Breaking Medicine Technology:BridgePoint Medical(R) Receives European CE Mark for Stingray(R) and CrossBoss(TM) for Opening Completely Blocked Arteries 2Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 2Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 3Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 2Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 3Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 4Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 5Obama Signs Tough New Anti Smoking Law 49671 1Obama Signs Tough New Anti Smoking Law 49671 2Amgen to Participate in Reproductive Health Drugs Advisory Committee Meeting in August 12732 1Amgen to Participate in Reproductive Health Drugs Advisory Committee Meeting in August 12732 2Amgen to Participate in Reproductive Health Drugs Advisory Committee Meeting in August 12732 3Amgen to Participate in Reproductive Health Drugs Advisory Committee Meeting in August 12732 4Amgen to Participate in Reproductive Health Drugs Advisory Committee Meeting in August 12732 5Amgen to Participate in Reproductive Health Drugs Advisory Committee Meeting in August 12732 6Amgen to Participate in Reproductive Health Drugs Advisory Committee Meeting in August 12732 7Vermont Receives National Award for Physician e Prescribing Thanks to Efforts by Local Healthcare Firm 49668 1Vermont Receives National Award for Physician e Prescribing Thanks to Efforts by Local Healthcare Firm 49668 2
... Va., Jan. 4 Innocoll, Inc., a privately-held,spe...first of a series of,planned phase 2 clinical tria...ll Technologies Ltd, to investigate CollaRx(R) BUP...st-operative pain, has commenced dosing., Innocol...e and fully,bioresorbable matrix of purified fibri...
...Calif., Jan. 3 Watson,Pharmaceuticals, Inc. (NYSE...ny, announced today it has launched Clarithromycin...gth. Watson,s Clarithromycin,Extended-Release prod...),XL, which is indicated to treat or prevent infec...caused by susceptible bacteria. For the 12-months,...
Other Medicine Technology:Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain 2Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain 3Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain 4Watson Launches Generic Biaxin(R) XL 2
8-multi channel rack
...c PTFE membranes,Millex filter units with hydropho...ing filtration of gases, for venting of sterile co...c solutions. Ready-to-use sterile 25 mm Millex fil...ections; other filter units can be autoclaved prio...
...icity personal water system is an economical alter... water. In addition to the ongoing expense to purc...y applications may be at risk - as contamination c...lity to degrade over time. Simplicity ultrapure wa...
...r, , Ultrapure Water Quality On Demand, The Super-...lish" to water which has been pretreated by revers...lus systems consistently produce ultrapure water q...cations.,The Super-Q Plus water system features a ...
Medicine Products: